Altium Capital Management LP Portfolio Holdings

Altium Capital Management LP

  • $301 Million
  • Q4 2024

Altium Capital Management LP has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $301 Million distributed in 67 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $23.9M, Vera Therapeutics, Inc. with a value of $18.3M, Sarepta Therapeutics, Inc. with a value of $15.4M, Establishment Labs Holdings Inc. with a value of $14.1M, and Edwards Lifesciences Corp with a value of $12.2M.

Examining the 13F form we can see an increase of $17.5M in the current position value, from $283M to 301M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $301 Million
Healthcare: $300 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.11B
$23.9 Million 7.95% of portfolio
1,395,000
Q4 2024 Added 2.57%
$773M
$18.3 Million 6.07% of portfolio
432,000
Q4 2024 Reduced 36.84%
$9.31B
$15.4 Million 5.13% of portfolio
127,000
Q4 2024 Reduced 25.29%
$811M
$14.1 Million 4.67% of portfolio
305,000
Q4 2024 Added 132.82%
$45.3B
$12.2 Million 4.06% of portfolio
165,000
Q4 2024 Reduced 25.68%
$363M
$12.2 Million 4.04% of portfolio
1,424,400
Q4 2024 New
$2.47B
$11.3 Million 3.75% of portfolio
288,000
Q4 2024 Reduced 20.13%
$365M
$9.89 Million 3.29% of portfolio
714,000
Q4 2024 Added 150.53%
$818M
$9.8 Million 3.26% of portfolio
285,000
Q4 2024 Added 154.46%
$5.87B
$9.67 Million 3.21% of portfolio
100,000
Q4 2024 Added 17.65%
$170M
$9.14 Million 3.04% of portfolio
1,850,000
Q4 2024 Added 8.82%
$11B
$9.11 Million 3.03% of portfolio
132,000
Q4 2024 Added 1.54%
$182M
$8.08 Million 2.69% of portfolio
1,694,000
Q4 2024 Reduced 0.35%
$785M
$7.56 Million 2.51% of portfolio
685,000
Q4 2024 Added 92.96%
$12.1B
$6.26 Million 2.08% of portfolio
75,000
Q4 2024 Reduced 51.3%
$35.7B
$6.15 Million 2.04% of portfolio
10,000
Q4 2024 New
$34.1B
$5.95 Million 1.98% of portfolio
26,000
Q4 2024 New
$2.61B
$5.88 Million 1.95% of portfolio
146,000
Q4 2024 Added 15.87%
$8.72B
$5.62 Million 1.87% of portfolio
100,000
Q4 2024 New
$334M
$5.53 Million 1.84% of portfolio
815,000
Q4 2024 Added 63.0%
$2.22B
$5.32 Million 1.77% of portfolio
255,000
Q4 2024 Reduced 33.77%
$927M
$4.89 Million 1.63% of portfolio
370,000
Q4 2024 New
$307M
$4.85 Million 1.61% of portfolio
1,579,000
Q4 2024 Added 0.25%
$2.11B
$4.33 Million 1.44% of portfolio
230,257
Q4 2024 Reduced 35.14%
$156M
$3.64 Million 1.21% of portfolio
485,000
Q4 2024 New
$61.7M
$3.41 Million 1.13% of portfolio
7,415,413
Q2 2024 Reduced 3.04%
$4.49B
$2.86 Million 0.95% of portfolio
95,000
Q4 2024 New
$304M
$2.86 Million 0.95% of portfolio
355,000
Q3 2024 Reduced 12.35%
$174M
$2.79 Million 0.93% of portfolio
3,000,000
Q4 2024 Added 26,172.0%
$284M
$2.77 Million 0.92% of portfolio
175,000
Q4 2024 Added 153.62%
$1.37B
$2.71 Million 0.9% of portfolio
1,060,000
Q4 2024 New
$155M
$2.65 Million 0.88% of portfolio
475,000
Q4 2024 Added 43.94%
$3.63B
$2.62 Million 0.87% of portfolio
60,000
Q4 2024 New
$75.8M
$2.56 Million 0.85% of portfolio
1,428,000
Q4 2024 New
$1.11B
$2.43 Million 0.81% of portfolio
264,562
Q4 2024 New
$138M
$1.93 Million 0.64% of portfolio
505,000
Q4 2024 Reduced 27.13%
$185M
$1.57 Million 0.52% of portfolio
575,000
Q4 2024 New
$45.7M
$1.32 Million 0.44% of portfolio
2,028,534
Q3 2024 Reduced 10.9%
$9.33M
$1.16 Million 0.39% of portfolio
1,473,000
Q3 2024 New
$35.7M
$914,000 0.3% of portfolio
310,000
Q4 2024 Added 29.75%
$346M
$564,000 0.19% of portfolio
40,352
Q4 2024 Reduced 52.53%
$0
$540,000 0.18% of portfolio
581,395
Q3 2024 New
$200M
$525,000 0.17% of portfolio
111,812
Q4 2024 New
$47.9M
$503,000 0.17% of portfolio
740,000
Q2 2023 Added 46.31%
$51.4M
$481,000 0.16% of portfolio
467,491
Q4 2024 Reduced 48.91%
Avadel Pharmaceuticals PLC
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 25.82%
Perspective Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 68.2%
Better Choice CO Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 11.01%
Anteris Technologies Global
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 67
  • Current Value $301 Million
  • Prior Value $283 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 19 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email